Surgical Site Infection Market

DelveInsight's "Surgical Site Infection Market" report provides a thorough comprehension of the Surgical Site Infection, historical and forecasted epidemiology, and the Surgical Site Infection market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Surgical Site Infection market report also proffers an analysis of the current Surgical Site Infection treatment algorithm/practice, market drivers, market barriers, and unmet medical needs. 

Some of the vital takeaways of the Surgical Site Infection Market Research Report 

  • A slew of companies such as Zurex Pharma, Dr. Reddy's Laboratories Ltd., Botanix Pharma, Menarini Group Pharma, PolyPid, Destiny Pharma, and others are developing Surgical Site Infection therapies to influence treatment outlook. 
  • In Nov 2020, PolyPid Ltd. announced that D-PLEX100 received Breakthrough Therapy Designation from the US Food and Drug Administration to prevent Surgical Site Infections in patients undergoing elective colorectal surgery.
  • The prophylactic therapy segment is XF-73 under development by Destiny Pharma with its antimicrobial "XF" drug platform. XF-73 was awarded QIDP status in October 2015.
  • Presently the emerging therapies such as XF-73, D-PLEX100, DFA-02, BTX 1801, ZuraGard, and others are focused on treating or preventing Surgical Site Infection in either cardio or abdominal surgeries in the prophylactic segment, while Delafloxacin is used for the Surgical Site Infection treatment. 
  • Under the Surgical Site Infection treatment market, Delafloxacin by Menarini Group is the only upcoming therapy for a patient with incisional, superficial or deep, surgical site infection after cardiothoracic/related leg or abdominal surgery.
  • Delafloxacin, under the name of Baxdela (fluoroquinolone antibacterial), received FDA approval for the Acute Bacterial Skin and Skin Structure Infections treatment, announced by Melinta Therapeutics in June 2017. 
  • Menarini Group and Melinta Therapeutics entered into a co-development and commercial agreement in 68 Countries for Delafloxacin in 2017. 
  • The future development of new modalities in Surgical Site Infection treatment and prophylaxis appears promising during the forecast period of 2021–2030. Of the emerging therapies, XF-73, D-PLEX100, BTX 1801, Delafloxacin, DFA-02, Zuragard, and others are expected to change the Surgical Site Infection market scenario in the upcoming years. 

View Sample Report: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market

Request for free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

For further information on Market Impact by Therapies, visit: 

 Surgical Site Infections (SSIs) are the most common nosocomial infection and frequently cause morbidity and mortality among patients of hospitals. 

As per DelveInsight's research, the total Surgical Site Infection Incident cases in the 7MM were 1,323,491 cases in 2018. Moreover, it is observed that males and females are equally affected.

Surgical Site Infection Emerging Therapies Along with Key Players

  • XF-73: Destiny Pharma
  • D-PLEX100: PolyPid
  • Delafloxacin: Menarini Group Pharma
  • BTX 1801: Botanix Pharma
  • DFA-02: Dr Reddy's Laboratories Ltd.
  • Zuragard: Zurex Pharma 
  • And several others.

Get a sample copy of this report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

Request for free Sample Report: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market

Scope of the Surgical Site Infection Market Insight Report 

  • Geography Covered: The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. 
  • Study Period: 3-year historical and 10-year forecasted analysis (2018-2030).
  • Surgical Site Infection Markets Segmentation: By Geographies and By Surgical Site Infection Therapies (Historical and Forecasted, Current and Upcoming) 
  • Dominant Market Companies investigating its candidates for Surgical Site Infection: Zurex Pharma, Dr. Reddy's Laboratories Ltd., Botanix Pharma, Menarini Group Pharma, PolyPid, Destiny Pharma, and several others. 
  • Analysis: Comparative and conjoint analysis of emerging therapies. 
  • Case Studies
  • KOL's Views
  • Analyst's View

Request for free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

View Sample Report: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market

Table of Contents 

1

Surgical Site Infection Key Insights

2

Surgical Site Infection Report Introduction

3

Surgical Site Infection Prophylactic Market Overview at a Glance

4

Surgical Site Infection Treatment Market Overview at a Glance

5

Surgical Site Infection Executive Summary

6

Surgical Site Infection Disease Background and Overview 

7

Surgical Site Infection Epidemiology and Patient Population

7.1

The United States

7.2

EU5 Countries

7.2.1

Germany

7.2.2

France

7.2.3

Italy

7.2.4

Spain

7.2.5

The United Kingdom

7.3

Japan

8

Surgical Site Infection Treatment and Management 

9

Surgical Site Infection Prevention

10

Organizations contributing towards Surgical Site Infection

11

Surgical Site Infection Patient Journey

12

Surgical Site Infection Case Report

13

Surgical Site Infection Emerging Therapies

13.1

XF-73: Destiny Pharma

13.2

 D-PLEX100: PolyPid

13.3

Delafloxacin: Menarini Group Pharma

13.4

BTX 1801: Botanix Pharma

13.5

DFA-02: Dr. Reddy's Laboratories Ltd.

13.6

Zuragard: Zurex Pharma

14

7MM Surgical Site Infection Market Analysis

14.1

The United States Surgical Site Infection Market Size

14.2

EU-5 Surgical Site Infection Market Size

14.2.1

Germany Market Size

14.2.2

France Market Size

14.2.3

Italy Market Size

14.2.4

Spain Market Size

14.2.5

The United Kingdom Market Size

14.3

Japan Surgical Site Infection Market Size

15

Surgical Site Infection Market Drivers

16

Surgical Site Infection Market Barriers

17

SWOT Analysis of Surgical Site Infection

18

Surgical Site Infection Unmet Needs

19

Appendix

20

DelveInsight Capabilities

21

Disclaimer

22

About DelveInsight

Request for Detailed TOC: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

View Related Reports       

DelveInsight's Surgical Site Infections (SSI) - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Surgical Site Infections (SSI) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Surgical Site Infections (SSI) Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Surgical Site Infections (SSI) market.

DelveInsight's Acute Bacterial Skin and Skin Structure Infections - Market Insights, Epidemiology, and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

DelveInsight's Chronic Pulmonary Infections due to Pseudomonas Aeruginosa in patients with Cystic Fibrosis - Market Insights, Epidemiology and Market Forecast - 2030 report provide a detailed overview of the disease and in-depth understanding of historical and forecasted epidemiology.

DelveInsight's Clostridium Difficile Infections Market Insights, Epidemiology, and Forecast 2030 report provides a detailed overview of the disease & understanding of forecasted epidemiology.

Complicated Intra-Abdominal Infections market research report delivers in-depth analysis of the Complicated Intra-Abdominal Infections market size & share, epidemiology, and pipeline insights.

Related Reports:

·         Cataplexy Market

Related Blogs:

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Contact us

 Ankit Nigam

 info@delveinsight.com

 +91-9650213330

 https://www.delveinsight.com/

 Connect With Us at:

 LinkedIn | Facebook | Twitter

Request for free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more

Test

  Partial Seizure Market | Parkinson's Disease Levodopa-Induced Dyskinesia Market | Metabolic Acidosis Market | Hepatitis D Market | Gaucher's disease Market | Gastric Neuroendocrine Tumours Market | Familial Chylomicronemia Syndrome Market | Exocrine Pancreatic Insufficiency Market | Crohn's Disease Market | Contact Dermatitis Market | Concussions Market Size | Chronic Bronchitis Market | Chondrosarcoma Market | Palmar Hyperhidrosis Market | Hpv Induced Cancers Market | Alstrom Syndrome Market | Astigmatism Market | Meningioma Market | Central Retinal Vein Occlusion Market | Intracranial Pressure Monitoring Devices Market | Head And Neck Squamous Cell Carcinoma Market | Hyperopia Market | Thyroid Eye Disease Market | Rett Syndrome Market | Cipn Market | Chemotherapy Induced Peripheral Neuropathy Market | Idiopathic Membranous Nephropathy Market | Walking Impairment In Multiple Sclerosis Market  |  Triple Negative Breast Cancer Market  | Sjogren&#
Read more